Caladrius Biosciences
Caladrius Biosciences is a clinical-stage biopharmaceutical company focused on the development of innovative therapies to address unmet medical needs. Specializing in regenerative medicine and cell therapy, Caladrius Biosciences leverages advanced technologies to develop novel treatments for diseases with limited therapeutic options. The company’s pipeline includes product candidates targeting conditions such as cardiovascular disease and autoimmune disorders. With a commitment to rigorous research and clinical excellence, Caladrius Biosciences aims to deliver safe and effective therapies that improve patient outcomes. The company collaborates with industry partners and research institutions to advance its mission of transforming the treatment landscape through cutting-edge biopharmaceutical innovation.
